跳至主要内容
临床试验/CTIS2024-515001-26-00
CTIS2024-515001-26-00进行中(未招募)1 期

PROPHYLACTIC ANTIBIOTIC TREATMENT IN END-STAGE KIDNEY DISEASE AND CENTRAL VENOUS CATHETER AS HEMODIALYSIS VASCULAR ACCESS - 12020

Region Sjaelland0 个研究点目标入组 800 人开始时间: 2024年6月25日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • End Stage Kidney Disease (ESKD) patients who receive an uncuffed or cuffed CVC for expected chronic HD, regardless of previous ESKD treatment modality (PD or KTX) and hemodialysis access (AV-fistula or AV-graft))

排除标准

  • Unable to give informed consent, Known intolerance to beta-lactam antibiotics and clindamycin, Active infection treated with antibiotics, Pregnancy. In women of childbearing age, an approved birth control must be ensured, Patients may be rescreened later i.e. within a time period of one month from start of HD, if exclusion criteria are reversible

研究者

发起方
Region Sjaelland

相似试验